Where CBPMs Are Most Frequently Considered in UK Specialist Practice
A clinician-focused overview of the indications where cannabis-based products for medicinal use are most often considere...
Read MoreTag: CBPMs
Medical Cannabis and Mental Health in UK Practice: Evidence, Risk, and Safe-Prescribing Posture
A clinician-focused review of CBPMs in UK mental-health practice: psychosis risk literature, anxiety and PTSD registry d...
Read More
Cannabis Terpenes and the Entourage Hypothesis: What the Clinical Evidence Actually Says
A clinician-focused review of cannabis terpenes, the entourage hypothesis, receptor evidence, COA interpretation and wha...
Read More
The European Medical Cannabis Landscape in 2026: What UK Stakeholders Should Know
Germany, Netherlands, Czech Republic, Poland, Italy and France in 2026 — a country-by-country brief for UK prescribers...
Read More
CBPM Supply Chain in the UK: WDA, Specials, and the Continuity Question
How CBPMs reach UK clinics — WDA(H), Specials Manufacturing, Home Office licences, QP responsibility, storage, audit t...
Read More
Prescribing CBPMs in the UK: A Practical Guide to the Specialist Pathway
A practical guide for specialist clinicians on prescribing cannabis-based products for medicinal use (CBPMs) in the UK â...
Read More